7 Signs Your Melanoma Has Spread
Melanoma is among the most aggressive forms of skin cancer, and recognizing when it begins to spread beyond the original tumor site is critical for timely intervention. Understanding the signs melanoma has spread to other organs can make a meaningful difference in the outcomes patients and caregivers experience.
Key Takeaways
- Melanoma can spread to the lymph nodes, lungs, liver, brain, and bones, often causing symptoms specific to those areas.
- Swollen lymph nodes near the original tumor site are frequently among the earliest detectable warning signs.
- Fatigue, unexplained weight loss, and neurological changes are common systemic symptoms of metastatic melanoma.
- Symptoms of metastatic melanoma can be subtle and may resemble other conditions, making medical evaluation essential.
- Early reporting of new or worsening symptoms to an oncologist improves the likelihood of effective treatment.
7 Signs Your Melanoma Has Spread to Watch for Early
Metastatic melanoma refers to melanoma that has traveled from its original site on the skin to distant tissues or organs through the lymphatic system or bloodstream. According to the American Cancer Society, about 4% of melanoma cases are diagnosed at the metastatic stage, when five-year survival rates drop significantly compared to localized disease. Recognizing early warning signs gives patients and physicians the opportunity to act before the disease progresses further.
The seven most important warning signs melanoma is spreading include changes you may notice yourself as well as symptoms that require clinical evaluation. Being familiar with these signs enables patients to seek timely care rather than waiting for symptoms to become severe.
- Swollen or hardened lymph nodes near the original tumor site or in the neck, armpits, or groin
- Persistent fatigue that is disproportionate to activity level and does not improve with rest
- Unexplained weight loss occurring without dietary changes
- New lumps or nodules beneath the skin surface, particularly near old surgical scars
- Respiratory symptoms such as a lasting cough, shortness of breath, or chest pain
- Neurological changes including persistent headaches, visual disturbances, confusion, or seizures
- Bone pain or fractures occurring with minimal trauma, suggesting skeletal involvement
Not every symptom on this list will appear in every patient, and some individuals experience only one or two of these signs before a diagnosis of spread is confirmed. That is why consistent monitoring and open communication with an oncologist remain essential after any initial melanoma diagnosis.
How Melanoma Spreads: Lymph Nodes, Organs, and Beyond
Melanoma spreads through two primary routes: the lymphatic system and the bloodstream. When cancer cells enter the lymphatic vessels, they are carried toward nearby lymph nodes, where they may establish secondary tumors. This is why the signs melanoma spread to lymph nodes are often the first metastatic indicators a clinician evaluates during staging workup.
Once melanoma cells reach the bloodstream, they gain access to distant organs. Research published in peer-reviewed oncology literature consistently identifies the lungs, liver, brain, and bones as the most common sites of distant metastasis. The brain is particularly vulnerable; approximately 40–60% of patients with advanced melanoma develop brain metastases at some point during their illness, according to data cited by the Melanoma Research Foundation.
What happens when melanoma spreads in the body depends heavily on which organ is affected and how many metastatic lesions are present. Spread to the liver may elevate certain liver enzymes and cause abdominal discomfort, while pulmonary metastases can compromise respiratory capacity. The pattern of spread influences both prognosis and the selection of systemic therapies such as immunotherapy or targeted treatments.
Sentinel lymph node biopsy, positron emission tomography (PET) scans, computed tomography (CT) scans, and magnetic resonance imaging (MRI) are the standard diagnostic tools used to detect and map the extent of melanoma metastasis. Staging findings directly determine which treatment pathways are most appropriate for a given patient.
Symptoms of Metastatic Melanoma by Affected Body Region
The symptoms of metastatic melanoma vary depending on where secondary tumors have formed. Because melanoma can reach virtually any organ system, symptoms are often organ-specific and may initially be mistaken for unrelated conditions. A structured understanding of regional symptoms helps patients and caregivers identify patterns that warrant urgent evaluation.
Systemic symptoms such as profound fatigue, anorexia, and unintentional weight loss can appear regardless of which organ is involved, as they reflect the overall metabolic burden of widespread cancer. These generalized findings are important but are not sufficient on their own to localize metastatic disease.
| Affected Region | Common Symptoms |
|---|---|
| Lymph nodes | Firm, painless swelling near the primary tumor site or in the axilla, groin, or neck |
| Lungs | Persistent dry cough, shortness of breath, chest pain, or coughing up blood |
| Liver | Right-sided abdominal pain, jaundice, nausea, or abdominal swelling |
| Brain | Headaches, confusion, memory problems, seizures, or vision changes |
| Bones | Deep, aching bone pain, tenderness, or fractures with minimal force |
| Skin/Subcutaneous tissue | New nodules or lumps beneath the skin, particularly near prior surgical sites |
The melanoma metastasis symptoms to watch for in the skin and subcutaneous tissue are often overlooked because patients may assume any new growth near an old incision is simply scar tissue. Any new, firm, or rapidly growing nodule in the vicinity of a prior melanoma excision site should be reported to an oncologist without delay.
Liver and lung involvement frequently produces symptoms only after significant tumor burden has developed, as both organs have substantial functional reserve. This physiological buffer can mask early-stage organ metastases, which reinforces the value of scheduled imaging surveillance for individuals with high-risk or previously treated melanoma.
When to See a Doctor If You Suspect Melanoma Metastasis
Prompt medical consultation is warranted whenever a melanoma survivor develops new, unexplained physical changes, particularly those described in the sections above. The distinction between a minor, unrelated complaint and a genuine warning sign melanoma is spreading can be difficult to make without clinical expertise and diagnostic imaging, so erring on the side of early evaluation is always advisable.
Specific circumstances that should prompt immediate contact with an oncologist or emergency care provider include a new or worsening seizure, sudden confusion or personality change, unexplained fractures, rapidly enlarging lymph nodes, or significant difficulty breathing. These symptoms may reflect rapid disease progression that benefits from urgent staging and treatment adjustment.
For individuals without acute symptoms but with a history of melanoma, adherence to a scheduled surveillance program is essential. The National Comprehensive Cancer Network (NCCN) recommends periodic skin examinations, lymph node assessments, and imaging studies at intervals determined by the original stage of disease and individual risk factors. Keeping these appointments even when feeling well allows clinicians to detect subclinical metastasis before it becomes symptomatic.
Open, transparent communication with the treating oncology team is equally important. Patients should document new symptoms—including their onset, character, and duration—and share this information at each appointment. A symptom diary can be a practical tool for capturing details that might otherwise be forgotten during a brief clinical encounter. Together, vigilant self-monitoring and structured medical follow-up represent the most effective strategy for identifying spread at the earliest actionable stage.
Frequently Asked Questions
Can melanoma spread without any visible skin changes?
Yes. Once melanoma enters the lymphatic system or bloodstream, it can establish tumors in internal organs without producing noticeable changes at the original skin site. This is why individuals with a prior melanoma diagnosis should undergo regular imaging and lymph node evaluations even when the skin appears normal. Internal metastases are frequently detected through scheduled scans rather than from symptoms alone, particularly in their earlier stages.
Is metastatic melanoma always fatal?
Not necessarily. Advances in immunotherapy—particularly immune checkpoint inhibitors such as pembrolizumab and nivolumab—have substantially improved long-term survival rates for some patients with metastatic melanoma. Targeted therapies for tumors carrying BRAF mutations have also changed the treatment landscape. While metastatic melanoma remains a serious diagnosis, a meaningful proportion of patients achieve durable responses. Outcomes depend on the extent of spread, treatment response, and overall health status.
Are the symptoms of metastatic melanoma different from other cancers?
Many symptoms—such as fatigue, weight loss, and lymph node swelling—overlap with those of other cancers and non-cancerous conditions. What distinguishes melanoma metastasis is the clinical context: a patient with a history of melanoma who develops these symptoms requires evaluation specifically for disease progression. Additionally, melanoma has a notable tendency to spread to the brain and skin, which can produce neurological symptoms or subcutaneous nodules less common with some other cancer types.
